In 2012 infirst Healthcare was spun out of SEEK a UK based drug discovery group. Its initial products aim to improve treatments for the management of common cough, inflammatory pain, as well as chronic wounds. In the US infirst also develops and markets effective treatments for Gastro Intestinal (GI) symptoms.
infirst Healthcare believes that improvements in treatments should be noticeable, perceivable and result in a better quality of life for sufferers. infirst Healthcare aims to contribute to minimising the number of health situations which require escalated and specialised medical intervention.
The company’s Leadership Team has many decades of experience in the pharmaceutical and consumer healthcare industries and they have developed, managed and grown large healthcare businesses and brands in the UK, Europe and North America.
The development of infirst Healthcare’s programme would not have been possible without the invaluable inputs of our many external partners. We would like to thank them for their continued support, shared passion and belief in our mission.
Around a third of people aged 45 years and over in the UK, a total of 8.75 million people, have sought treatment for osteoarthritis